#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rheumatoid arthritis Waldenstrom's macroglobulinaemia Optic ischaemic neuropathy Gaucher's disease type I Hidradenitis Hepatocellular carcinoma Exudative retinopathy Endometrial cancer Cold type haemolytic anaemia ROHHAD syndrome Arterial tortuosity syndrome Hepatic angiosarcoma Pelizaeus-Merzbacher disease B-cell small lymphocytic lymphoma recurrent Cerebral haemorrhage More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Treatment Systemic mastocytosis – Diagnostics Fragile X syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria – Diagnostics Angiosarcoma non-metastatic – Treatment Immunodeficiency congenital Leiomyosarcoma recurrent – Trials in Disease Loeys-Dietz syndrome – Basic Information Inclusion body myositis – Basic Information Progressive multifocal leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acalabrutinib Ramipril Zinc Oxide Crd-4730 Heparin Calcium LTG-001 CARBOMER 980 HYPOCHLOROUS ACID Dicloxacillin Cefixime Prednisolone Acetate Dapagliflozin Propanediol Betula Verrucosa (108) Lovotibeglogene Autotemcel Gad20-209-Fsp-A1 Xylitol GSKVX000000048111 Tezacaftor Trometamol Dinoprostone More therapies…

    Learn about Your Condition

    Neonatal respiratory failure Urticaria chronic Cutaneous calcification Endometrial cancer End stage renal disease Gaucher's disease type I Staphylococcal bacteraemia Cytokine release syndrome Breast cancer Device related infection Transitional cell carcinoma Psoriasis Micrographic skin surgery Osteoporosis postmenopausal Chronic lymphocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

    Not recruiting

    2 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Bemcentinib
    Belgium Czechia France Greece Ireland Italy +4

  • Study of Zilovertamab Vedotin with Drug Combination for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Gemcitabine
    • Oxaliplatin
    Denmark France Greece Italy Poland

  • Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

    Not recruiting

    3 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • (6E)-6-[(6-Chloro-2-Methyl-2H-Indazol-5-Yl)Imino]-3-[(1-Methyl-1H-1,2,4-Triazol-3-Yl)Methyl]-1-[(2,4,5-Trifluorophenyl)Methyl]-1,3,5-Triazinane-2,4-Dione
    Denmark Germany Greece Ireland Poland Spain

  • Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

    Not recruiting

    3 1
    Investigated Drugs:
    • Benralizumab
    Austria Belgium Bulgaria Czechia Denmark Germany +7

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn’s Disease After Anti-TNF Therapy Failure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Risankizumab
    • Ustekinumab
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

    Not recruiting

    3 1
    Investigated Drugs:
    • Astegolimab
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lenalidomide
    • Obinutuzumab
    • Rituximab
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Isatuximab
    • Pegenzileukin
    France Germany Greece Italy Norway Portugal

  • Study of Isatuximab with Lenalidomide and Dexamethasone for Elderly Patients (70+) with Newly Diagnosed Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    Austria Greece
Previous Page
1 … 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!